Cargando…
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
BACKGROUND: The reliable diagnosis rate of diagnostic tests is provided by their intervals with acceptable accuracy (e.g. ≥90%) where a liver biopsy can be avoided. AIMS: To evaluate the overall accuracy and improve the reliable diagnosis rates of blood tests for significant liver fibrosis. METHODS:...
Autores principales: | Calès, Paul, de Ledinghen, Victor, Halfon, Philippe, Bacq, Yannick, Leroy, Vincent, Boursier, Jérôme, Foucher, Juliette, Bourlière, Marc, de Muret, Anne, Sturm, Nathalie, Hunault, Gilles, Oberti, Frédéric |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711538/ https://www.ncbi.nlm.nih.gov/pubmed/18492022 http://dx.doi.org/10.1111/j.1478-3231.2008.01789.x |
Ejemplares similares
-
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
por: Berger, Arthur, et al.
Publicado: (2019) -
A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis
por: Calès, Paul, et al.
Publicado: (2018) -
Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C
por: Boursier, Jérôme, et al.
Publicado: (2011) -
Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2020) -
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
por: Boursier, Jérôme, et al.
Publicado: (2023)